| 000 | 01666 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517034318.0 | ||
| 264 | 0 | _c20160324 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/srep10979 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChang, Ya-Hsuan | |
| 245 | 0 | 0 |
_aPathway-based gene signatures predicting clinical outcome of lung adenocarcinoma. _h[electronic resource] |
| 260 |
_bScientific reports _cJun 2015 |
||
| 300 |
_a10979 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xgenetics |
| 650 | 0 | 4 | _aAdenocarcinoma of Lung |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xgenetics |
| 650 | 0 | 4 |
_aClathrin-Coated Vesicles _xmetabolism |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 |
_aHMGB1 Protein _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aLung Neoplasms _xgenetics |
| 650 | 0 | 4 | _aMAP Kinase Signaling System |
| 650 | 0 | 4 | _aPatient Outcome Assessment |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aReceptor for Advanced Glycation End Products _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, beta _xmetabolism |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aTranscriptome |
| 700 | 1 | _aChen, Chung-Ming | |
| 700 | 1 | _aChen, Hsuan-Yu | |
| 700 | 1 | _aYang, Pan-Chyr | |
| 773 | 0 |
_tScientific reports _gvol. 5 _gp. 10979 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/srep10979 _zAvailable from publisher's website |
| 999 |
_c24951044 _d24951044 |
||